Affinivax's Series B Round

Affinivax raised a round of funding on January 05, 2018. Investors include Alta Partners.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious disease…

Articles about Affinivax's Series B Round: